Poland· PL-100361232
Nevirapine Accord
A nevirapine product containing nevirapinum, registered in Poland by Accord Healthcare Polska Sp. z o.o.. The same ATC class is registered in 16 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Nevirapine is registered in 16 of 19 countries.
Countries holding a registration under ATC J05AG01 (nevirapine), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 9 of them publish a price we can compare per daily dose
Nevirapine · ATC J05AG01
16 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of nevirapine costs, country by country.
Normalised to the WHO defined daily dose (0.4 g), the median price runs from $3.81 in France to $7.77 in Switzerland — a ×2.0 gap.
- 2 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Nevirapine · price per daily dose (0.4 g)
USD · FX 28 Sept 2026
- CH Switzerland$7.77
- FR France$3.81
The record
At a glance
URPL (Poland)- Active substance
- Nevirapinum
- Manufacturer
- Accord Healthcare Polska Sp. z o.o.
- Country
- Poland (PL)
- ATC code
- J05AG01
- ATC class
- Nevirapine
- Defined daily dose
- 0.4 g, O
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 6
- gtin05909991340926
- gtin05909991340933
- gtin05909991340940
- gtin05909991397166
- gtin05909991397173
- gtin05909991397180
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
316 interactions on record for nevirapine.
Graded by severity as the source publishes them — 26 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Nevirapine · interactions on record
316 records
- 26 severe
- 220 moderate
- 8 minor
- 49 info
Most severe, free to view
- DeflazacortH02AB13severe
- BrigatinibL01ED04severe
- LorlatinibL01ED05severe
- CobimetinibL01EE02severe
13 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Nevirapine in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomNevirapine 200mg tabletsCreo Pharma Ltd
- United StatesNevirapineMacleods Pharmaceuticals Limited
- SpainNEVIRAPINA ACCORD 200 mg COMPRIMIDOS EFGAccord Healthcare S.L.U.
- NetherlandsNevirapine Accord 200 mg, tablettenAccord Healthcare B.V.
- FinlandNevirapine SandozSandoz A/S
- FranceNEVIRAPINE ARROW LAB 200 mg, compriméARROW GENERIQUES
- CzechiaVIRAMUNEBoehringer Ingelheim International GmbH, Ingelheim am Rhein
- CanadaAURO-NEVIRAPINEAURO PHARMA INC
Authorised across Europe · EMA
The same active substance is authorised in 18 EEA countries. Names it is sold under:
- Austria · Nevirapin Viatris
- Belgium · Nevirapine Viatris
- Germany · Nevirapin Abdi, Nevirapin Aurobindo
- Denmark · Nevirapine Medical Valley, Nevirapine Viatris
- Spain · Nevirapina Aurovitas, Nevirapina Kern Pharma
- Finland · Nevirapine Viatris
- France · Nevirapine Arrow Lab, Nevirapine Cristers
- United Kingdom (Northern Ireland) · Nevirapine Accord, Nevirapine Accord Healthcare
- Greece · Nevirapine Vocate
- Iceland · Viramune
- Italy · Nevirapina Aurobindo, Nevirapina Mylan
- Liechtenstein · Viramune
- Luxembourg · Nevirapine Viatris
- Netherlands · Nevirapine Accord, Nevirapine Amarox
- Norway · Viramune
- Portugal · Nevirapina Accord, Nevirapina Aurovitas
- Romania · Nevirapina Accord, Nevirapină Accord
- Sweden · Nevirapine Medical Valley
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/53f1f906-3023-4157-b9e9-79bd45b79f2a GET /v1/drugs/53f1f906-3023-4157-b9e9-79bd45b79f2a?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tabletki",
"source": "urpl",
"strength": "200 mg",
"packaging": "05909991340926 ¦ Rpz ¦ 123881\n14 tabl.\n05909991340933 ¦ Rpz ¦ 123882\n60 tabl. w blistrze\n05909991340940 ¦ Rpz ¦ 123883\n120 tabl. w blistrze\n05909991397166 ¦ Rpz ¦ 131785\n60 tabl. w blistrze perforowanym\n05909991397173 ¦ Rpz ¦ 131786\n120 tabl. w blistrze perforowanym\n05909991397180 ¦ Rpz ¦ 131787\n180 tabl.",
"substance": "Nevirapinum anhydricum 200 mg",
"common_name": "Nevirapinum",
"pl_product_id": "100361232",
"pozwolenie_nr": "24183",
"auth_procedure": "DCP",
"authorisation_validity": "2023-12-11"
}See everything about nevirapine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.